Written and maintained by CASRAI Editorial Board
Last updated
Pharmacology is the scientific study of how drugs and other chemical substances interact with living systems — how they are absorbed, distributed, broken down, and eliminated by the body (pharmacokinetics), and how they produce their biological effects at the molecular, cellular, and whole-organism level (pharmacodynamics). It sits at the intersection of chemistry, physiology, and medicine: pharmacologists ask what a substance does to the body, how the body handles the substance in return, and how that relationship can be used deliberately — to treat disease, to understand normal physiology by perturbing it, or to explain toxicity and side effects.
The word comes from the Greek pharmakon (drug or remedy) and logos (study). In practice, pharmacology covers the full life cycle of a chemical agent’s relationship with a biological system: how a molecule is discovered or designed, how it binds a receptor or enzyme, how the dose relates to the response, how the body metabolizes and clears it, and how all of that translates into a therapy that is both effective and safe in real patients.
What pharmacology actually studies
Pharmacology is organized around a small number of core questions that apply to any drug, from aspirin to a modern biologic:
- Pharmacodynamics — what the drug does to the body: the mechanism of action, typically through binding a specific receptor, enzyme, ion channel, or transporter, and the resulting biochemical or physiological effect. Dose–response relationships, potency, efficacy, and receptor theory (agonists, antagonists, partial agonists) all fall under pharmacodynamics.
- Pharmacokinetics — what the body does to the drug: absorption, distribution, metabolism, and excretion (often abbreviated ADME). This determines how much of a dose reaches its target, how long it stays active, and how frequently it must be given.
- Pharmacogenomics — how an individual’s genetic makeup affects their response to a drug, explaining why the same dose can be effective in one person and ineffective or toxic in another.
- Toxicology — the study of adverse effects, closely related to pharmacology and sometimes taught as a subfield of it, though it is also a distinct discipline in its own right (see CASRAI’s What Is Toxicology? guide).
A central organizing idea across all of this is the dose–response relationship: essentially every biologically active substance produces different effects across a range of doses, and pharmacology’s job is to characterize that relationship precisely enough to find a dose that is therapeutic without being toxic — the concept underlying the “therapeutic index” or “therapeutic window” used throughout drug development and clinical dosing.
How pharmacology relates to neighboring disciplines
Pharmacology is inherently interdisciplinary, and its boundaries with adjacent fields are porous by design:
- Biochemistry supplies the molecular vocabulary — enzyme kinetics, receptor structure, signal transduction — that pharmacology applies to drug action specifically. See CASRAI’s What Is Biochemistry? guide for the underlying chemistry of living systems.
- Physiology provides the normal-function baseline against which a drug’s effect is measured; pharmacologists often use drugs as tools to probe how an organ system normally works.
- Medicinal chemistry focuses further upstream, on designing and synthesizing the molecules that pharmacology then characterizes biologically.
- Toxicology asks the mirror-image question — not “what dose treats disease” but “what dose or exposure causes harm” — and the two fields share methods (dose–response curves, receptor binding assays) even where their questions diverge.
- Clinical medicine and pharmacy apply pharmacological principles directly to patient care; a PharmD (Doctor of Pharmacy) is a clinical practice degree distinct from the PhD research training described below.
- Epidemiology intersects with pharmacology in pharmacoepidemiology — studying drug effects and safety at the population level rather than the individual level (see CASRAI’s What Is Epidemiology? guide).
Major subfields of pharmacology
Pharmacology departments and journals typically organize the field into overlapping subfields, distinguished by the organ system, drug class, or level of analysis involved:
- Molecular and cellular pharmacology — drug–receptor interactions and intracellular signaling at the molecular level.
- Clinical pharmacology — how drugs behave in actual patients, including dose optimization, drug interactions, and special populations (pediatric, geriatric, renal/hepatic impairment).
- Neuropharmacology — drugs acting on the nervous system, overlapping heavily with neuroscience (see CASRAI’s What Is Neuroscience? guide) and including the related subfield of psychopharmacology, which focuses specifically on drugs affecting mood, cognition, and behavior.
- Cardiovascular pharmacology — drugs acting on the heart and vasculature.
- Cancer pharmacology (pharmaco-oncology) — the mechanisms and development of chemotherapeutic and targeted cancer agents.
- Immunopharmacology — drugs that modulate the immune system, from vaccines to immunosuppressants to modern immunotherapies.
- Pharmacogenomics — genetic determinants of individual drug response, increasingly central to “precision medicine” dosing.
- Pharmacoepidemiology — population-level study of drug effects, safety signals, and utilization patterns, often using large real-world healthcare datasets.
- Veterinary pharmacology — drug action and dosing across animal species, which differ meaningfully from human pharmacokinetics.
How pharmacology research is funded
In the United States, pharmacology research is funded predominantly through the National Institutes of Health (NIH) rather than a single dedicated institute — because pharmacology is a methodology applied across nearly every disease area, funding is distributed across many NIH institutes according to their disease or system focus. The National Institute of General Medical Sciences (NIGMS) is the institute most associated with foundational, non-disease-specific pharmacology, since its mission explicitly names pharmacology alongside cell biology, biochemistry, and genetics as core supported disciplines. Disease- and system-focused institutes fund pharmacology work relevant to their own remit — for example, work on drugs of abuse falls under the National Institute on Drug Abuse, cancer therapeutics under the National Cancer Institute, psychiatric drug mechanisms under the National Institute of Mental Health, and neurological drug targets under the National Institute of Neurological Disorders and Stroke.
The National Science Foundation (NSF) funds some of the foundational chemistry and biology that pharmacology draws on — for instance through its Chemistry and Molecular and Cellular Biosciences programs — but translational and therapeutic pharmacology work in the U.S. is funded predominantly through NIH rather than NSF.
Outside U.S. federal funding, several large biomedical research foundations are active funders of pharmacology-adjacent research, including the Wellcome Trust (UK-based, with a long history of funding drug-discovery and molecular pharmacology research globally) and the Bill & Melinda Gates Foundation (funding pharmacology relevant to global health priorities such as antimalarial and antiviral drug development). A substantial share of applied and clinical pharmacology research — particularly late-stage drug development — is also funded directly by pharmaceutical and biotechnology companies, alongside academic and government funding; industry sponsorship is a major, distinct channel from public grant funding and carries its own disclosure and conflict-of-interest norms in academic publishing.
Research methods, tools, and equipment
Pharmacology research spans a wide range of techniques, generally moving from molecular characterization toward whole-organism and population-level study:
- In vitro assays — receptor-binding assays, enzyme-inhibition assays, and cell-culture-based functional assays used to characterize how a compound interacts with its molecular target.
- High-throughput screening — automated testing of large compound libraries against a biological target, standard in early drug discovery.
- Analytical chemistry instrumentation — high-performance liquid chromatography (HPLC) and mass spectrometry are core tools for measuring drug concentrations in biological samples, underpinning pharmacokinetic studies.
- Electrophysiology — techniques such as patch-clamp recording, used especially in neuropharmacology and cardiovascular pharmacology to measure a drug’s effect on ion channel activity.
- Animal models — in vivo studies used to characterize pharmacokinetics, efficacy, and toxicity before a compound advances to human trials, governed by well-established animal-welfare and regulatory oversight frameworks.
- Computational and in silico pharmacology — molecular docking, quantitative structure-activity relationship (QSAR) modeling, and pharmacokinetic/pharmacodynamic (PK/PD) modeling software used to predict drug behavior before or alongside laboratory testing.
- Clinical trials — the human-subjects stage of translational pharmacology, where the earlier laboratory and animal findings are tested for safety and efficacy in people; see CASRAI’s clinical-research cluster for the full trial-phase and regulatory framework.
Career and training pathways
Two distinct professional tracks lead into pharmacology, and they are commonly confused:
- Research pharmacology is typically pursued through a PhD in pharmacology or a closely related discipline (biochemistry, molecular biology, physiology), usually housed in a university’s pharmacology department or a medical school’s basic-science division. Doctoral training generally runs several years and combines coursework with an original research project, often followed by a postdoctoral research position before an independent academic, government, or industry research role.
- Clinical pharmacy practice runs through the PharmD (Doctor of Pharmacy), a professional clinical degree focused on medication therapy management and patient care rather than original laboratory research — a different pathway from the PhD research track, though the two fields draw on the same underlying pharmacological science.
Two long-established professional societies are widely recognized reference points for the field: the American Society for Pharmacology and Experimental Therapeutics (ASPET) in the United States, and the British Pharmacological Society (BPS) in the United Kingdom. Both publish peer-reviewed pharmacology journals and hold regular scientific meetings that serve as a professional home for researchers across the subfields above.
Frequently asked questions
Is pharmacology the same as pharmacy?
No. Pharmacology is the scientific study of how drugs interact with biological systems; pharmacy is the clinical health profession concerned with dispensing medications, counseling patients, and managing medication therapy. A pharmacologist typically holds a PhD and works in research; a pharmacist typically holds a PharmD and works in clinical or community practice. The two fields share a knowledge base but lead to different careers.
Is pharmacology the same as toxicology?
They are closely related but distinct. Pharmacology generally asks what dose of a substance produces a therapeutic effect; toxicology generally asks what dose or exposure produces harm. Many methods overlap (dose–response analysis, receptor binding), and some departments teach them together, but toxicology also extends beyond drugs to environmental and industrial chemicals, which fall outside pharmacology’s traditional scope. See CASRAI’s What Is Toxicology? guide for more.
What is the difference between pharmacokinetics and pharmacodynamics?
Pharmacokinetics is what the body does to a drug (absorption, distribution, metabolism, excretion); pharmacodynamics is what the drug does to the body (its mechanism of action and effect). A useful shorthand: pharmacokinetics determines how much drug reaches its target and for how long, and pharmacodynamics determines what happens once it gets there.
What degree do you need to become a pharmacologist?
Research pharmacologists generally hold a PhD in pharmacology or a related biomedical science. Clinical pharmacists, a related but distinct profession, hold a PharmD. Some professionals pursue combined MD/PhD or PharmD/PhD training, particularly for translational or clinical-pharmacology research roles.
